Amgen (AMGN)
(Delayed Data from NSDQ)
$332.45 USD
+2.39 (0.72%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $332.00 -0.45 (-0.14%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum C VGM
Price, Consensus and EPS Surprise
AMGN 332.45 +2.39(0.72%)
Will AMGN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AMGN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AMGN
VRDN Stock Soars as Eye Disorder Study Meets Primary Endpoints
Why Amgen (AMGN) Outpaced the Stock Market Today
AMGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Amgen (AMGN) Up 5.8% Since Last Earnings Report: Can It Continue?
Other News for AMGN
SCHD's 5 Worst Dividend Stocks You Can Buy Today
BlackRock Health Sciences Term Trust Q2 2024 Commentary
AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024
Viridian Therapeutics price target raised by $9 at RBC Capital, here's why
Time To Invest And Or Trade In Bio-Tech Stocks?